These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 27696580

  • 21. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
    Turner-Stokes L, Jacinto J, Fheodoroff K, Brashear A, Maisonobe P, Lysandropoulos A, Ashford S, Upper Limb International Spasticity (ULIS-III) study group.
    J Rehabil Med; 2021 Feb 24; 53(2):jrm00157. PubMed ID: 33616192
    [Abstract] [Full Text] [Related]

  • 22. Botulinum toxin type A in post-stroke upper limb spasticity.
    Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M, GSK1358820 Spasticity Study Group.
    Curr Med Res Opin; 2010 Aug 24; 26(8):1983-92. PubMed ID: 20569068
    [Abstract] [Full Text] [Related]

  • 23. Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on upper and lower limb spasticity in post-stroke patients.
    Hara T, Abo M, Hara H, Kobayashi K, Shimamoto Y, Samizo Y, Sasaki N, Yamada N, Niimi M.
    Int J Neurosci; 2017 Jun 24; 127(6):469-478. PubMed ID: 27256591
    [Abstract] [Full Text] [Related]

  • 24. Does botulinum toxin treatment improve upper limb active function?
    Levy J, Molteni F, Cannaviello G, Lansaman T, Roche N, Bensmail D.
    Ann Phys Rehabil Med; 2019 Jul 24; 62(4):234-240. PubMed ID: 29960017
    [Abstract] [Full Text] [Related]

  • 25. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD, Vuadens P, van Wijck FM, Stark S, Johnson GR, Barnes MP.
    Clin Rehabil; 2002 Sep 24; 16(6):654-60. PubMed ID: 12392341
    [Abstract] [Full Text] [Related]

  • 26. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ, Nott MT, Turner-Stokes L, De Graaff S, Katrak P, McCrory P, de Abadal M, Hughes A.
    J Rehabil Med; 2011 Nov 24; 43(11):1032-7. PubMed ID: 22031350
    [Abstract] [Full Text] [Related]

  • 27. Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on lower limb spasticity classified by spastic muscle echo intensity in post-stroke patients.
    Hara T, Abo M, Hara H, Kobayashi K, Shimamoto Y, Shibata Y, Sasaki N, Yamada N, Niimi M.
    Int J Neurosci; 2018 May 24; 128(5):412-420. PubMed ID: 28985683
    [Abstract] [Full Text] [Related]

  • 28. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.
    Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M, GSK1358820 Spasticity Study Group.
    J Neurol; 2010 Aug 24; 257(8):1330-7. PubMed ID: 20358216
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS, Park YG, Paik NJ, Oh BM, Chun MH, Yang HE, Kim DH, Yi Y, Seo HG, Kim KD, Chang MC, Ryu JH, Lee SU.
    J Neurol Sci; 2015 Oct 15; 357(1-2):192-7. PubMed ID: 26233808
    [Abstract] [Full Text] [Related]

  • 30. Functional goal achievement in post-stroke spasticity patients: the BOTOX® Economic Spasticity Trial (BEST).
    Ward AB, Wissel J, Borg J, Ertzgaard P, Herrmann C, Kulkarni J, Lindgren K, Reuter I, Sakel M, Säterö P, Sharma S, Wein T, Wright N, Fulford-Smith A, BEST Study Group.
    J Rehabil Med; 2014 Jun 15; 46(6):504-13. PubMed ID: 24715249
    [Abstract] [Full Text] [Related]

  • 31. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A, Micello MF, Panza F, Fortunato F, Picelli A, Smania N, Logroscino G, Fiore P, Ranieri M.
    Clin Rehabil; 2015 Jan 15; 29(1):50-8. PubMed ID: 24917588
    [Abstract] [Full Text] [Related]

  • 32. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
    Ashford S, Turner-Stokes L.
    Disabil Rehabil; 2009 Jan 15; 31(3):220-6. PubMed ID: 18608366
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study.
    Datta Gupta A, Visvanathan R, Cameron I, Koblar SA, Howell S, Wilson D.
    BMC Neurol; 2019 May 11; 19(1):96. PubMed ID: 31078139
    [Abstract] [Full Text] [Related]

  • 34. Combined therapy using botulinum toxin A and single-joint hybrid assistive limb for upper-limb disability due to spastic hemiplegia.
    Saita K, Morishita T, Hyakutake K, Fukuda H, Shiota E, Sankai Y, Inoue T.
    J Neurol Sci; 2017 Feb 15; 373():182-187. PubMed ID: 28131185
    [Abstract] [Full Text] [Related]

  • 35. Common goal areas in the treatment of upper limb spasticity: a multicentre analysis.
    Ashford S, Fheodoroff K, Jacinto J, Turner-Stokes L.
    Clin Rehabil; 2016 Jun 15; 30(6):617-22. PubMed ID: 26141809
    [Abstract] [Full Text] [Related]

  • 36. Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.
    Seo HG, Paik NJ, Lee SU, Oh BM, Chun MH, Kwon BS, Bang MS.
    PLoS One; 2015 Jun 15; 10(6):e0128633. PubMed ID: 26030192
    [Abstract] [Full Text] [Related]

  • 37. The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: an international survey.
    Bakheit AM, Zakine B, Maisonobe P, Aymard C, Fhedoroff K, Hefter H, Jacinto J, Jost WH, Molteni F, Stam H, Turner-Stokes L, Wissel J.
    Int J Rehabil Res; 2010 Sep 15; 33(3):199-204. PubMed ID: 20154631
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.
    Lee J, Chun MH, Ko YJ, Lee SU, Kim DY, Paik NJ, Kwon BS, Park YG.
    Arch Phys Med Rehabil; 2020 Sep 15; 101(9):1485-1496. PubMed ID: 32497599
    [Abstract] [Full Text] [Related]

  • 39. Botulinum Toxin Type A Treatment Combined with Intensive Rehabilitation for Gait Poststroke: A Preliminary Study.
    Uchiyama Y, Koyama T, Wada Y, Katsutani M, Kodama N, Domen K.
    J Stroke Cerebrovasc Dis; 2018 Jul 15; 27(7):1975-1986. PubMed ID: 29610039
    [Abstract] [Full Text] [Related]

  • 40. Extracorporeal Shock Waves Versus Botulinum Toxin Type A in the Treatment of Poststroke Upper Limb Spasticity: A Randomized Noninferiority Trial.
    Wu YT, Yu HK, Chen LR, Chang CN, Chen YM, Hu GC.
    Arch Phys Med Rehabil; 2018 Nov 15; 99(11):2143-2150. PubMed ID: 30392753
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.